Core Viewpoint - Dechang Co., Ltd. has achieved significant growth in both its home appliance and automotive parts businesses, with a notable increase in revenue and net profit for the year 2024 [1][2]. Group 1: Financial Performance - In 2024, Dechang Co. reported a revenue of 4.095 billion yuan, representing a year-on-year increase of 47.56% [1] - The net profit attributable to shareholders reached 411 million yuan, up 27.51% year-on-year [1] - The net profit excluding non-recurring gains and losses was 393 million yuan, reflecting a growth of 24.93% [1] Group 2: Business Segments - The home appliance segment generated a revenue of 2.124 billion yuan from vacuum cleaners, marking a 30.22% increase [1] - The small home appliance segment achieved a revenue of 1.386 billion yuan, with a remarkable growth of 68.60% [1] - The automotive parts business, initiated in 2017, generated 412 million yuan in revenue for 2024, a substantial increase of 104.54% [2] Group 3: Strategic Initiatives - Dechang Co. plans to raise up to 1.524 billion yuan through a private placement to fund various projects, including the construction of manufacturing facilities in Thailand and Vietnam [2][3] - The company aims to alleviate capacity constraints in its small home appliances and EPS motor products, enhancing supply and profitability [2][3] - As of the end of 2024, the total investment from the IPO proceeds reached 1.487 billion yuan, with an investment progress of 98.16% [4]

中国经济网北京4月29日讯紫建电子（301121）(301121.SZ)今日收报47.60元，跌幅10.15%。目前该股股 价处于破发状态。 紫建电子于2022年8月8日在深交所创业板上市，公开发行股份总数为1,770.0800万股，占发行后股份总 数的25.00%，不低于公司发行后股份总数的25.00%，发行价格为61.07元/股。2022年8月19日，紫建电 子创下上市以来股价高点122.49元，此后股价震荡下跌。 紫建电子发行募集资金总额为108,098.79万元，扣除发行费用后，实际募集资金净额为96,702.20万元。 紫建电子最终募集资金净额较原计划多47,894.41万元。紫建电子2022年8月3日披露的招股书显示，公司 拟募集资金48,807.79万元，计划用于消费类锂离子电池扩产项目、紫建研发中心建设项目、补充流动资 金。 紫建电子的保荐机构(主承销商)为国金证券股份有限公司，保荐代表人为余烯键、谢丰峰。紫建电子发 行费用总额为11,396.58万元，其中，国金证券股份有限公司获得承销及保荐费用8,810.05万元。 紫建电子2024年年度报告显示，经公司第二届董事会第二十次会议审议通过的利 ...

以下文章来源于解码LP ，作者吴琼 解码LP . 投资界（PEdaily.cn）旗下，专注募资动态 欢迎加入投资界读者群 募资不易。 作者 I 吴琼 报道 I 投资界-解码LP 募资最新一幕。 投资界—解码LP获悉，国家中小企业发展基金有限公司完成第七批第一支子基金签约工 作，即深创投中小企业发展基金（苏州）合伙企业（有限合伙），总规模20亿元。这一 次，深创投为新基金管理人。 放眼创投圈，国家中小企业发展基金向来出手活跃。此次签约拉开第七批子基金序幕， 意味着有望迎来一波密集出资。对于一众苦于募资的GP而言，一场新比拼开始了。 国家级母基金，投了深创投 从过往出资来看，国家中小企业发展基金对GP的遴选颇为严格。印象深刻的是，去年6 月母基金一口气出资6家GP，包括普华资本、基石资本、达晨财智、元璟资本、通和毓 承、国中资本等知名机构。其实这次也并非国家中小企业发展基金首次联手深创投，此 前深创投中小企业发展基金（新疆）有限合伙企业已在新疆乌鲁木齐成立。 时间回到去年7月，国家中小企业发展基金发布第七批子基金管理机构遴选公告，子基金 将通过市场化手段扩大对中小企业的股权投资规模，支持投早投小投创新，重点支持种 ...

中国经济网北京4月28日讯日联科技(688531.SH)今日收报63.40元，跌幅7.01%。 日联科技首次公开发行股票的发行费用合计29,416.06万元(不含税)，其中海通证券股份有限公司获得保 荐承销费用26,178.79万元。 海通创新证券投资有限公司按照股票发行价格认购日联科技本次公开发行股票数量3%的股票，即 595,541股，跟投金额90,748,537.58元。 2025年4月11日，国泰海通证券股份有限公司重组更名上市仪式在上交所举行。上交所与国泰海通签订 《证券上市协议》，国泰海通证券股份有限公司A股证券简称由"国泰君安"正式变更为"国泰海通"，A 股证券代码"601211"保持不变。证券简称变更，标志着国泰君安、海通证券合并重组走完了全部程序。 日联科技于2023年3月31日在上交所科创板上市，公开发行股票1,985.1367万股，发行价格为152.38元/ 股，保荐机构(主承销商)为海通证券股份有限公司，保荐代表人为黄科峰、吴志君。 上市首日，日联科技盘中最高报241.11元，创上市以来股价最高点，此后该股股价震荡下跌，目前该股 处于破发状态。 日联科技首次公开发行股票募集资金总额30 ...

Core Points - Gannee Pharmaceutical recently disclosed a significant change in shareholder equity, with Beijing Xute Hongda Technology Co., Ltd. reducing its stake in the company [1][2] - The equity change period was from April 22, 2025, to April 24, 2025, during which Xute Hongda reduced its holdings by 849,822 shares, representing 0.14% of Gannee's total share capital [1][2] - After the change, Xute Hongda holds 40,634,035 shares, accounting for 6.76% of Gannee's total share capital, while its concerted actor, Gan Zhongru, holds 205,643,757 shares, representing 34.21% [1][2] Company Information - Gan Zhongru is the largest shareholder of Gannee Pharmaceutical, while Xute Hongda is the second largest shareholder [2] - Gan Zhongru has been the controlling shareholder and actual controller of Gannee since 2020, serving as the chairman of the company [2] - Gannee Pharmaceutical was listed on the Shanghai Stock Exchange on June 29, 2020, with an initial public offering (IPO) of 40.2 million shares at a price of 63.32 yuan per share [2][3] Fundraising Activities - Gannee Pharmaceutical raised a total of 2.545 billion yuan through its IPO, with a net amount of 2.441 billion yuan after expenses [2][3] - The funds raised were intended for various projects, including marketing network construction and the registration of insulin products in the U.S. [2] - In 2023, Gannee issued 28,508,550 shares at a price of 27.12 yuan per share, raising approximately 773.15 million yuan, with a net amount of about 759.73 million yuan after expenses [3]

就终止2024年度以简易程序向特定对象发行股票事项的原因，金龙汽车表示，自公司公告2024年度以简 易程序向特定对象发行股票事项以来，公司董事会、管理层与中介机构等一直积极推进各项工作。在综 合考虑目前资本市场环境、公司实际情况及公司发展规划等诸多因素，并与相关各方充分沟通及审慎分 析后，现决定终止2024年度以简易程序向特定对象发行股票的相关事项。 金龙汽车表示，目前公司生产经营正常，本次终止2024年度以简易程序向特定对象发行股票的相关事 项，不会对公司生产经营和业务发展造成重大不利影响，不存在损害公司及全体股东、特别是中小股东 利益的情形。 根据金龙汽车于2024年7月16日披露的《2024年度以简易程序向特定对象发行股票预案》，该公司原拟 向特定对象发行股票的募集资金总额不超过30,000万元(含本数)，扣除发行费用后拟将募集资金全部用 于金龙全球化商旅客车平台开发项目。 中国经济网北京4月28日讯金龙汽车（600686）(600686.SH)近日发布公告称，公司于2025年4月24日召 开第十一届董事会第十三次会议、第十一届监事会第十二次会议，审议通过了《关于终止2024年度以简 易程序向特定对象发 ...

（文/霍东阳 编辑/张广凯） 夹在这一波年轻的现制茶饮上市潮中，有个餐饮老将显得格外扎眼。与沪上阿姨同天通过聆讯，第五次 递表的初代"网红餐厅"绿茶也披露了聆讯后的招股书。 自2021年3月以来，绿茶五次递交上市招股书、三次通过聆讯，曾经距离敲钟上市仅一步之遥，却又因 种种原因无功而返。如今，绿茶的业绩已难复当年之勇，单店收入和翻台率持续下滑，只能靠大量开店 拉动营收增长，却同时背上了巨大的流动负债压力。再次叩响港交所大门的绿茶，这次能否成功挂牌 呢？ 在大众点评、小红书的网络平台尚未完全兴起时，绿茶曾提供了一种"网红范本"：高颜值和独特口感 的"爆品"，辅以精致门店装修风格的"场景"，以及二者结合让消费者自发拍照而形成的"社交货币"。 随着市场竞争加剧，绿茶"高性价比+网红流量"的打法逐渐失效，关键经营指标持续下滑。2024年，绿 茶录得38.38亿的收入，较前一年仅增长6.5%。 | | | | 截至12月31日止年度 | | | | | --- | --- | --- | --- | --- | --- | --- | | | 2022年 | | 2023年 | | 2024年 | | | | 人民幣 ...

Core Insights - Bain & Company released the "2025 China Private Equity Market Report," indicating a slight recovery in investment transactions, reaching $47 billion in 2024 after two years of decline [1][3][4] Investment Trends - The total investment transaction amount in China's private equity market for 2024 is projected to be $47 billion, reflecting a 7% increase from the previous year, driven by a rise in large-scale transactions [3] - Growth-type investments continue to dominate, accounting for approximately 60% of the total transaction volume, while controlling-type investments have seen a significant increase, making up 29% of the total, a historical high [3][4] - The most active investment sectors are semiconductors and new energy vehicles, primarily led by RMB funds, while USD funds focus more on healthcare and services [3] Market Dynamics - The report suggests that the Chinese private equity market is entering a transformation phase, with expectations of stabilization and recovery in the future [2][4] - The fundraising environment remains challenging, with only 25% of top funds successfully raising capital, and a trend towards concentration in fundraising among leading funds, which now account for 70% of total fundraising [4][6] Exit Strategies - Exit transactions, particularly IPOs, have been declining, leading private equity funds to seek alternative exit strategies, such as transactions with strategic buyers [5][6] - The report indicates that private equity funds are exploring new strategies, shifting from growth-type investments to controlling-type investments, and leveraging unique advantages in China's supply chain and R&D capabilities [6]

Financial Data - The company reported a net fundraising amount of RMB 1,073.03 million from its initial public offering, with excess funds amounting to RMB 203.36 million [21][23] - The company plans to use RMB 30 million of the excess funds to permanently supplement its working capital, which represents 14.75% of the total excess funds [21][24] Board Meeting - The second board meeting of the company was held on April 24, 2025, with all five directors present, and the resolutions passed were deemed legal and effective [5][6] - The board approved the proposal to use part of the excess funds for working capital, with unanimous support from all directors [7][8] Supervisory Board Meeting - The second supervisory board meeting was also held on April 24, 2025, with all three supervisors present, and the resolutions were confirmed to comply with legal and regulatory requirements [14][15] - The supervisory board agreed with the proposal to use part of the excess funds for working capital, emphasizing its benefits for the company's operational efficiency [17][26] Upcoming Shareholder Meeting - A second extraordinary general meeting of shareholders is scheduled for May 20, 2025, to review the proposals approved by the board [29][30] - The meeting will utilize a combination of on-site and online voting methods, allowing shareholders to participate remotely [30][31] Investor Communication - The company will hold an investor briefing on April 29, 2025, to discuss the 2024 annual report and the first quarter of 2025, allowing for interactive communication with investors [40][41] - Investors can submit questions via email prior to the meeting, which will be addressed during the session [42][44]

星标 ★ IPO日报 精彩文章第一时间推送 按产品划分，2024年上半年，光伏逆变器为公司贡献了超七成的收入，为13.83亿元，储能双向变流器及系统集成产品收入5.07亿元，占总收入的 比重为26.34%。 简单来说，光伏逆变器能够将光伏组件产生的直流电转换为交流电，并接入电网或供本地负载使用，是光伏发电系统的核心设备。 日前，上能电气股份有限公司（300827.SZ，下称"上能电气"）定增募资计划已被深交所受理。 具体来看，公司拟向特定对象发行股票募集资金16.5亿元，扩产光伏逆变器及储能变流器，新增产能分别为25GW、15GW，达现有产能的2.08 倍、2.73倍。 制图：佘诗婕 海外收入增加 据了解，上能电气是一家专注于电力电子产品研发、制造与销售的国家高新技术企业，成立于2012年，前身为无锡上能新能源有限公司，2015年 更名为上能电气股份有限公司，2020年于深交所挂牌上市。 2024 年上半年，公司实现营业收入19.26 亿元，同比下降11.5%；归母净利润1.61 亿元，同比增长18.9%。 对此，公司称，营收下滑的主要原因在于储能系统集成业务有所减少，而归母净利润水平提升主要是由于海外收入占 ...